A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed.
A 12-month study conducted by researchers at Lawson Research Institute found that Ambroxol helped stabilise psychiatric symptoms, improved cognitive function, and protected against brain damage in genetically at-risk participants.
